Affimed NV (Affimed NV) Long-Term Debt : $6.89 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Affimed NV Long-Term Debt?

Affimed NV's Long-Term Debt for the quarter that ended in Dec. 2023 was $6.89 Mil.

Affimed NV's quarterly Long-Term Debt declined from Jun. 2023 ($9.75 Mil) to Sep. 2023 ($8.18 Mil) and declined from Sep. 2023 ($8.18 Mil) to Dec. 2023 ($6.89 Mil).

Affimed NV's annual Long-Term Debt declined from Dec. 2021 ($19.28 Mil) to Dec. 2022 ($12.38 Mil) and declined from Dec. 2022 ($12.38 Mil) to Dec. 2023 ($6.89 Mil).

Affimed NV Long-Term Debt Historical Data

The historical data trend for Affimed NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Long-Term Debt Chart

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

0.31

0.28

19.28

12.38

6.89

Affimed NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															12.38	11.08	9.75	8.18	6.89

Affimed NV (NAS:AFMD) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Affimed NV Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Affimed NV's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Affimed NV (Affimed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

A28:Germany

Address

Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.